The purpose of this study will be to see if Xdemvy (lotilaner ophthalmic solution) 0.25% has a positive impact on ocular surface symptoms and PROSE device func…

Demodex Blepharitis

~Estimated

~$25 – $1,500

Actual pay is set by the research site.

Boston SightNCT07561450

Phase 2

Multicenter, Randomized, Double-Masked, Placebo-Controlled, Parallel Group Phase 2 Trial Evaluating the Safety and Efficacy of GLK-321 in Subjects With Demodex Blepharitis

This is a randomized, double-masked, placebo-controlled, dose-ranging, parallel-group, multi-center study designed to evaluate the safety and efficacy of GLK-3…

Demodex Blepharitis

~Estimated

~$75 – $2,800

Actual pay is set by the research site.

Glaukos CorporationNCT07400965